RADIOFREQUENCY ABLATION OF MALIGNANT TUMORS OF THE TRANSPLANTED KIDNEY. A CLINICAL CASE
DOI:
https://doi.org/10.54890/.v3i3.1047Abstract
Summary: In the article on clinical example demonstrates the safety and efficacy of radiofrequency ablation of tumors of the transplanted kidney in a patient with chronic renal failure.
Keywords:
radiofrequency ablation, kidney cancer, transplantation.References
1. Godley P., Kim S.W. Renal cell carcinoma // Curr. Opin. Oncol. – 2002. – Vol.14. – P.280-285.
2. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 году. // Вестник Российского онкологического научного центра имени Н.Н. Блохина РАМН. 2010. Т. 22, №3. С. 54-92.
3. Escudier B, Eisen T, Porta C, Patard JJ, Khoo V, Algaba F, Mulders P, Kataja V. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. // Annals of Oncology. 2012. Vol. 23, Supp.7.P.65–71.
4. Miller DC, Ruterbusch J, Colt JS, Davis FG, Linehan WM, Chow WH, Schwartz K. Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study.// J Urol. 2010. Vol. 184, N6. P. 2254-2258.
5. Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. // Eur Urol. 2011. Vol. 59, N 1. P. 135-141.
6. Tillou X., Doerfler A., Collonb S., Kleinclauss F., Patard J.J., Badet L., Barrou B., Audet M., Bensadoun H., Berthoux E., Bigot P., Boutin J.M., Bouzguenda Y., Chambade D., Codas R., Dantal J., Deturmeny J., Devonec M., Dugardin F., Ferrière J.M., Erauso A., Feuillu B., Gigante M., Guy L., Karam G., Lebret T., Neuzillet Y., Legendre C., Perez T., Rerolle J.P., Salomon L., Sallusto F., Sénéchal C., Terrier N., Thuret R., Verhoest G., Petit J.; “Comité de Transplantation de l’AssociationFrançaised’Urologie (CTAFU)”. De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study. Am. J. Transplant. 2012;12:3308-3315.
7. 2. Rouprêt M., Peraldi M.N., Thaunat O., Chrétien Y., Thiounn N., Dufour B., Kreis H., Méjean A. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation. 2004;77(1):146-148.
8. 3. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation. 1995; 59: 480-492.
9. Chambade D., Meria P., Tariel E., Vérine J., De Kerviler E., Peraldi M.N., Glotz D., Desgrandchamps F., Mongiat-Artus P. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. J. Urol. 2008;180(5):2106-2109.
10. Gebauer B, Werk M, Lopez-Hänninen E, Felix R, Althaus P. //Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy// CardiovascInterv. Radiol. 2007 Jul-Aug; 30(4): 644-9.
11. Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y. //Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.// Int J Urol. 2007 Jul;14(7): 585-90; discussion 590.
Downloads
Published
How to Cite
Issue
Section
